Results 91 to 100 of about 19,418 (180)

Tigecycline resistance in Australian antibiotic-resistant Gram-negative bacteria [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2007
Jon, Iredell   +3 more
openaire   +2 more sources

Transient AdeABC-mediated eravacycline resistance in carbapenem-resistant Acinetobacter baumannii ST2: a mutation-independent efflux pump adaptation

open access: yesAnnals of Clinical Microbiology and Antimicrobials
Purpose This study evaluated the impact of sub-MIC eravacycline exposure on carbapenem-resistant Acinetobacter baumannii with tigecycline MIC ≥ 8 µg/mL in clinical laboratory testing, and analyzed the resistance mechanisms. Methods 2144 A.
Xu Yang   +6 more
doaj   +1 more source

Tigecycline Susceptibility of Carbapenem Resistant Enterobacteriaceae and Acinetobacter spp. isolates from Respiratory Tract: A Tertiary Care Centre Study [PDF]

open access: yesJournal of Krishna Institute of Medical Sciences University, 2020
Background: Tigecycline is used as a last line of defence against Multidrug Resistant (MDR) strains, and increasing rates of resistance are a growing concern globally. Tigecycline resistance has been reported in various pathogens including Acinetobacter
Ashish Bajaj   +7 more
doaj  

Comparative Genomic Analysis of Tigecycline Resistance Development in Clinical Acinetobacter baumannii Isolates

open access: yesInfection and Drug Resistance
Xiaoxia Li,1,* Junnian Liu,2,* Xinyu Zhang,1 Juan Li,3 Luhan Xuan,1 Sue Yuan,1 Jianglin Li,1 Yu Sun,1 Xuefei Du1 1Clinical Laboratory, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People’s Republic of
Li X   +8 more
doaj  

Genomic insights into tigecycline non-susceptibility in Clostridioides difficile: the role of the Tet P determinant and efflux mechanisms

open access: yesBMC Microbiology
Background Clostridioides difficile infection (CDI) is a significant cause of nosocomial infections, often arising from antibiotic-induced disruption of the normal gut microbiota, enabling C. difficile proliferation.
Zijun Dang   +6 more
doaj   +1 more source

Isoniazid potentiates tigecycline to kill methicillin-resistant Staphylococcus aureus

open access: yesEmerging Microbes & Infections
Therapeutic option for treating methicillin-resistant Staphylococcus aureus (MRSA) infection is urgently required since its resistance to a broad spectrum of currently available antibiotics. Here, we report that isoniazid is able to potentiate the killing efficacy of tigecycline to MRSA.
Xuan-wei Chen   +6 more
openaire   +3 more sources

Emergence of mobile tigecycline resistance mechanism in Escherichia coli strains from migratory birds in China

open access: green, 2021
Chong Chen   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy